Business Standard

Pakistan approves Russia's Sputnik-V Covid-19 vaccine for emergency use

Another candidate, developed by CanSino Biologics Inc(CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people

Serum Institute, Bharat Biotech ramp up Covid-19 vaccine export plan
Premium

Reuters
Russia's Sputnik-V has become the third COVID-19 vaccine to be approved by Pakistan for emergency use after China's Sinopharm and the one developed by AstraZeneca and Oxford University, the country's health minister said on Tuesday.
 
"Sputnik has received EUA (emergency use authorisation)," the minister, Faisal Sultan, told Reuters in a WhatsApp text message.
 
Another candidate, developed by CanSino Biologics Inc(CanSinoBIO), has also completed clinical trials in the South Asian nation of 220 million people.

What you get on BS Premium?

  • Unlock 30+ premium stories daily hand-picked by our editors, across devices on browser and app.
  • Pick your 5 favourite companies, get a daily email with all news updates on them.
  • Full access to our intuitive epaper - clip, save, share articles from any device; newspaper archives from 2006.
  • Preferential invites to Business Standard events.
  • Curated newsletters on markets, personal finance, policy & politics, start-ups, technology, and more.
VIEW ALL FAQs

Need More Information - write to us at assist@bsmail.in